REFERENCES
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China. The
Lancet. 2020;395(10223):497-506.
2. World Health O. Coronavirus disease 2019 (COVID-19): situation
report, 51. Geneva: World Health Organization; 2020 2020-03-11.
3. Bidari A, Asgarian S, Pour Mohammad A, Naderi D, Anaraki SR,
Gholizadeh Mesgarha M, et al. Immune thrombocytopenic purpura secondary
to COVID-19 vaccination: A systematic review. Eur J Haematol. 2022.
4. Moradians V, Shateri Amiri B, Bahadorizadeh L, Gholizadeh Mesgarha M,
Sadeghi S. Concurrent COVID-19 and pneumocystis carinii pneumonia in a
patient subsequently found to have underlying hairy cell leukemia.
Radiol Case Rep. 2022;17(9):3238-42.
5. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and
Multiorgan Response. Current Problems in Cardiology. 2020;45(8):100618.
6. Bahadorizadeh L, Emamikhah M, Pour Mohammad A, Gholizadeh Mesgarha M.
Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune
Thrombocytopenic Purpura in a Patient with a History of COVID-19
Infection. Neurol Ther. 2022;11(1):491-7.
7. Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, et
al. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on
Molecular Mechanisms, Immune Functions, Immunopathology and
Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines.
2021;9(5):436.
8. Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A,
et al. Coagulation dysfunction in COVID-19: The interplay between
inflammation, viral infection and the coagulation system. Blood Reviews.
2021;46:100745.
9. Maier CL, Truong AD, Auld SC, Polly DM, Tanksley C-L, Duncan A.
COVID-19-associated hyperviscosity: a link between inflammation and
thrombophilia? The Lancet. 2020;395(10239):1758-9.
10. Landau N, Shoenfeld Y, Negru L, Segal G. Exploring the pathways of
inflammation and coagulopathy in COVID-19: A narrative tour into a viral
rabbit hole. International Reviews of Immunology. 2022;41(4):414-22.
11. Cao Y, Hiyoshi A, Montgomery S. COVID-19 case-fatality rate and
demographic and socioeconomic influencers: worldwide spatial regression
analysis based on country-level data. BMJ Open. 2020;10(11):e043560.
12. Liao S-C, Shao S-C, Chen Y-T, Chen Y-C, Hung M-J. Incidence and
mortality of pulmonary embolism in COVID-19: a systematic review and
meta-analysis. Critical Care. 2020;24(1):464.
13. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G-J,
Harjola V-P, et al. 2019 ESC Guidelines for the diagnosis and management
of acute pulmonary embolism developed in collaboration with the European
Respiratory Society (ERS): The Task Force for the diagnosis and
management of acute pulmonary embolism of the European Society of
Cardiology (ESC). European Heart Journal. 2019;41(4):543-603.
14. Suarez Castillejo C, Toledo-Pons N, Calvo N, Ramon-Clar L, Martínez
J, Hermoso de Mendoza S, et al. A Prospective Study Evaluating
Cumulative Incidence and a Specific Prediction Rule in Pulmonary
Embolism in COVID-19. Front Med (Lausanne). 2022;9:936816.
15. Strazzulla A, Abroug Ben Halima S, Chouchane I, Rezek M, Pinto
Stiebler M, Hamrouni S, et al. The Predictive Value of Cell Blood Count
Parameters to Diagnose Pulmonary Embolism in Patients with SARS-CoV-2
Infection: A Case Control Study. Antibiotics [Internet]. 2022;
11(1).
16. Franco-Moreno AI, Bustamante-Fermosel A, Ruiz-Giardin JM,
Muñoz-Rivas N, Torres-Macho J, Brown-Lavalle D. Utilidad de las escalas
de predicción diagnósticas de embolia de pulmón en pacientes con
infección por SARS-CoV-2: una revisión sistemática. Revista Clínica
Española. 2023;223(1):40-9.
17. Aly MM, Meshref TS, Abdelhameid MA, Ahmed SA, Shaltout AS,
Abdel-Moniem AE, et al. Can Hematological Ratios Predict Outcome of
COVID-19 Patients? A Multicentric Study. J Blood Med. 2021;12:505-15.
18. Li X, Liu C, Mao Z, Xiao M, Wang L, Qi S, et al. Predictive values
of neutrophil-to-lymphocyte ratio on disease severity and mortality in
COVID-19 patients: a systematic review and meta-analysis. Critical Care.
2020;24(1):647.
19. Ayalew G, Mulugeta B, Haimanot Y, Adane T, Bayleyegn B, Abere A.
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Can
Predict the Severity in COVID-19 Patients from Ethiopia: A Retrospective
Study. Int J Gen Med. 2022;15:7701-8.
20. Wang Q, Ma J, Jiang Z, Ming L. Prognostic value of
neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute
pulmonary embolism: a systematic review and meta-analysis. Int Angiol.
2018;37(1):4-11.
21. Katsios CM, Donadini M, Meade M, Mehta S, Hall R, Granton J, et al.
Prediction Scores Do Not Correlate with Clinically Adjudicated
Categories of Pulmonary Embolism in Critically Ill Patients. Canadian
Respiratory Journal. 2014;21:296161.
22. Higaki A, Okayama H, Homma Y, Sano T, Kitai T, Yonetsu T, et al.
Predictive value of neutrophil-to-lymphocyte ratio for the fatality of
COVID-19 patients complicated with cardiovascular diseases and/or risk
factors. Sci Rep. 2022;12(1):13606.
23. Sarkar S, Kannan S, Khanna P, Singh AK. Role of
platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in
COVID-19: A systematic review and meta-analysis. J Med Virol.
2022;94(1):211-21.
24. Zinellu A, Mangoni AA. A systematic review and meta-analysis of the
association between the neutrophil, lymphocyte, and platelet count,
neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and
COVID-19 progression and mortality. Expert Rev Clin Immunol.
2022;18(11):1187-202.
25. Singh Y, Singh A, Rudravaram S, Soni KD, Aggarwal R, Patel N, et al.
Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as
Markers for Predicting the Severity in COVID-19 Patients: A Prospective
Observational Study. Indian J Crit Care Med. 2021;25(8):847-52.
26. Phan T, Brailovsky Y, Fareed J, Hoppensteadt D, Iqbal O, Darki A.
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict
All-Cause Mortality in Acute Pulmonary Embolism. Clin Appl Thromb
Hemost. 2020;26:1076029619900549.
27. Mureșan AV, Hălmaciu I, Arbănași EM, Kaller R, Arbănași EM, Budișcă
OA, et al. Prognostic Nutritional Index, Controlling Nutritional Status
(CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein
Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19
Patients. Diagnostics (Basel). 2022;12(11).
28. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, et al.
Simplification of the Pulmonary Embolism Severity Index for
Prognostication in Patients With Acute Symptomatic Pulmonary Embolism.
Archives of Internal Medicine. 2010;170(15):1383-9.
29. Miró Ò, Jiménez S, Llorens P, Roussel M, Gorlicki J,
García-Lamberechts EJ, et al. Pulmonary embolism severity and
in-hospital mortality: An international comparative study between
COVID-19 and non-COVID patients. Eur J Intern Med. 2022;98:69-76.
30. Thoreau B, Galland J, Delrue M, Neuwirth M, Stepanian A, Chauvin A,
et al. D-Dimer Level and Neutrophils Count as Predictive and Prognostic
Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients.
Viruses. 2021;13(5).